Table 2. Laboratory findings.
| Control (n = 60) | No MHE (n = 46) | MHE (n = 48) | CHE (n = 27) | |
|---|---|---|---|---|
| GLU (mmol/L) | 7.0 ± 3.6 | 6.3 ± 3.5 | 7.1 ± 5.5 | 7.8 ± 6.9 |
| WBC (109/L) | 8.3 ± 4.1 | 9.2 ± 3.7 | 9.1 ± 4.2 | 8.8 ± 3.8 |
| Neutrophils (%) | 59.5 ± 20.2 | 58.5 ± 21.6 | 62.2 ± 28.1 | 64.2 ± 22.6 |
| Lymphocytes (%) | 38.1 ± 15.5 | 37.2 ± 22.8 | 36.5 ± 19.8 | 39.9 ± 24.2 |
| HB (g/dL) | 120.1 ± 29.2 | 129.1 ± 33.2 | 117.4 ± 34.6 | 107.7 ± 25.7 |
| PLT (10/L) | 310.2 ± 113.5 | 288.1 ± 112.0 | 299.2 ± 161.1 | 273.8 ± 133.2 |
| ALT (IU/L) | 33.2 ± 6.5 | 65.1 ± 34.3 | 79.8 ± 53.7 | 123.3 ± 66.2 |
| AST (IU/L) | 26.7 ± 7.4 | 74.8 ± 48.7 | 87.4 ± 58.6 | 132.6 ± 71.7 |
| CK-MB (IU/L) | 19.2 ± 24.1 | 22.5 ± 29.4 | 27.1 ± 30.7 | 24.2 ± 23.6 |
| CRP (mg/L) | 4.3 ± 3.8 | 3.8 ± 3.5 | 4.6 ± 4.1 | 5.7 ± 4.6 |
| LDH (U/L) | 218.2 ± 75.1 | 241.4 ± 81.2 | 234.1 ± 65.8 | 242.5 ± 75.5 |
| K (mmol/L) | 4.1 ± 1.9 | 4.5 ± 1.4 | 4.7 ± 1.3 | 4.9 ± 1.7 |
| Na (mmol/L) | 130.6 ± 3.62 | 141.3 ± 5.5 | 133.3 ± 5.3 | 135.9 ± 7.6 |
| CL (mmol/L) | 100.5 ± 30.7 | 106.3 ± 45.2 | 115.9 ± 37.7 | 116.9 ± 41.6 |
| Prothrombin time (s) | 12.3 ± 3.0 | 18.8 ± 5.8 | 19.4 ± 6.3 | 19.1 ± 7.0 |
| Bilirubin (mg/dL) | 0.8 ± 0.6 | 2.8 ± 1.2 | 2.3 ± 0.8 | 2.7 ± 1.6 |
| Ammonia (uM) | 66.5 ± 34.3 | 161.2 ± 68.4 | 175.3 ± 54.6 | 178.8 ± 71.2 |
MHE: minimal hepatic encephalopathy, CHE: clinical hepatic encephalopathy, GLU: blood glucose, LYM: percentage of lymphocytes, ALT: alanine aminotransferase, CL: blood chlorine, WBC: white blood cell counts, CK: creatine kinase, CK-MB: creatine kinase-MB, CRP: C-reactive protein, LDH: Lactate dehydrogenase